Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases?

Domingo E, Marques P, Francisco V, Piqueras L, Sanz MJ

Open source

DOI
10.1016/j.phrs.2024.107058
Published
2024 Feb
Container
Pharmacological research
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.phrs.2024.107058,
  title = {Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases?},
  author = {Domingo E and Marques P and Francisco V and Piqueras L and Sanz MJ},
  year = {2024},
  journal = {Pharmacological research},
  doi = {10.1016/j.phrs.2024.107058},
  url = {https://doi.org/10.1016/j.phrs.2024.107058}
}

RIS

TY  - JOUR
TI  - Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases?
AU  - Domingo E
AU  - Marques P
AU  - Francisco V
AU  - Piqueras L
AU  - Sanz MJ
PY  - 2024
JO  - Pharmacological research
DO  - 10.1016/j.phrs.2024.107058
UR  - https://doi.org/10.1016/j.phrs.2024.107058
ER  - 

APA

E, D., P, M., V, F., L, P., & MJ, S. (2024). Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases?. Pharmacological research. https://doi.org/10.1016/j.phrs.2024.107058

Source records